Article
Assessment for bone health in patients with differentiated thyroid carcinoma after postoperative TSH suppression therapy: A new Fracture Risk Assessment Algorithm
2023-01-10
Abstract excerpt
<h4>Purpose: </h4> In the general population, the Fracture Risk Assessment tool (FRAX) is used to assess the 10-year risk of major site and hip fractures; however, it is unclear whether this tool can be applied to patients receiving levothyroxine-based Thyroid Stimulating Hormone (TSH) suppressive therapy for postoperative differentiated thyroid cancer patients. <h4>Methods: </h4> Sixty-four postoperative differen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1bd69d11-1b3f-5f0f-aae7-acf27b40c37d
- DOI
- 10.21203/rs.3.rs-2443260/v1
